Columbia University Medical Center (CUMC) has joined with Johnson &
Johnson in a partnership to establish a framework for translational
neuroscience that will foster new diagnostic tools and new drug
development for brain-related diseases. Nowhere are the opportunities
greater than in neuroscience and the need more pressing than in
psychiatric disorders and neurological diseases.

The establishment of the Paul Janssen Scholars Program in Translational
Neuroscience at CUMC serves as a lasting memorial in honor of one of the
great pharmacologists of our time, Dr. Paul Janssen (1926-2003). Dr.
Janssen is credited with laying the foundations for over 80 medications.
His life epitomized the search for knowledge and its practical
application in the clinic, the hallmarks of translational research.
Rooted in Columbia University Medical Center's preeminent strengths in
neuroscience research, education and patient care, the Janssen Scholars
Program will build upon Dr. Janssen's legacy of leadership and
excellence, and the search for cures and treatments for neurological and
psychiatric disorders.

The Scholars Program establishes the Paul Janssen Professorship of
Translational Neuroscience and the Paul Janssen Fellowship. Both will be
dedicated to the translation of basic research into clinical diagnostic
tests and new treatments for diseases of the brain, mind and body. This
two-year senior fellowship will be awarded to an outstanding young
investigator proposing novel translational research in the field of
neuroscience as it relates to psychiatric disease and medicine. The
first fellow will be named in the summer of 2005 and will be supervised
by Dr. John Mann the first Paul Janssen Professor of Translational
Neuroscience at Columbia University.

As a practicing clinician, Dr. John Mann personifies the "translational
scientist " with a unique ability to apply his laboratory findings to
the development of innovative brain imaging methods to study the brain
in living patients and in translating knowledge about basic mechanisms
of action of psychotropic medications into new effective treatment
methods for his patients. Dr. Mann is an exceptional, nationally
recognized researcher, an excellent teacher and a responsible clinician.
He is also an active contributor to academic and institutional life at
Columbia University.